AMPIO PHARMACEUTICALS INC - COM (AMPE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2023

Type / Class
Equity / COM
Symbol
AMPE on OTC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$1,000 0
2022 Q4 0 $0 -$1,725,813 0
2022 Q3 28,623,967 $1,728,198 -$394,575 $0.06 64
2022 Q2 29,493,527 $4,962,788 -$4,479,204 $0.17 98
2022 Q1 48,347,939 $22,700,996 -$5,968,243 $0.47 116
2021 Q4 59,148,855 $33,700,748 +$4,092,768 $0.57 128
2021 Q3 44,201,705 $72,596,740 +$24,735 $1.66 119
2021 Q2 45,183,272 $75,389,393 +$23,000,400 $1.67 127
2021 Q1 30,414,336 $51,494,362 +$9,902,841 $1.69 107
2020 Q4 25,161,021 $39,885,705 +$10,606,525 $1.59 97
2020 Q3 18,431,633 $17,489,372 +$1,256,162 $0.96 77
2020 Q2 17,435,249 $11,148,027 +$1,099,583 $0.64 71
2020 Q1 15,502,200 $6,436,653 +$174,732 $0.42 59
2019 Q4 14,998,274 $8,732,732 +$776,751 $0.58 73
2019 Q3 12,580,314 $6,283,131 -$3,158,727 $0.50 69
2019 Q2 20,486,761 $7,946,293 +$215,637 $0.39 71
2019 Q1 19,567,584 $10,991,196 +$779,332 $0.56 82
2018 Q4 18,067,717 $7,138,792 +$197,667 $0.40 75
2018 Q3 17,377,711 $8,812,105 -$5,204,059 $0.51 75
2018 Q2 17,384,275 $38,241,886 +$9,436,255 $2.20 80
2018 Q1 12,025,528 $40,882,485 +$11,137,617 $3.40 71
2017 Q4 8,675,595 $35,305,172 +$7,098,924 $4.07 53
2017 Q3 6,895,036 $4,232,015 -$955,732 $0.61 42
2017 Q2 8,732,054 $4,546,532 -$2,088,796 $0.52 54
2017 Q1 12,257,187 $9,805,140 -$1,566,088 $0.80 61
2016 Q4 14,155,442 $12,777,165 +$2,348,583 $0.90 67
2016 Q3 11,577,063 $8,621,605 -$436,571 $0.74 65
2016 Q2 11,983,662 $15,452,091 +$3,928,050 $1.29 69
2016 Q1 8,890,736 $20,017,108 -$100,635 $2.25 56
2015 Q4 8,861,165 $30,999,000 +$500,419 $3.50 56
2015 Q3 8,651,968 $25,002,940 -$3,416,284 $2.89 50
2015 Q2 9,900,155 $23,524,909 -$14,717,293 $2.37 62
2015 Q1 12,696,682 $95,573,291 +$5,138,332 $7.53 73
2014 Q4 12,108,717 $41,530,030 -$4,385,934 $3.43 68
2014 Q3 13,475,081 $47,667,028 -$4,196,607 $3.53 80
2014 Q2 13,883,212 $115,926,127 -$4,801,546 $8.35 73
2014 Q1 14,646,249 $92,936,155 +$5,228,590 $6.35 77